Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Role of Raf kinase inhibitor protein in Helicobacter pylori-mediated signaling in gastric cancer.

Nisimova L, Wen S, Cross-Knorr S, Rogers AB, Moss SF, Chatterjee D.

Crit Rev Oncog. 2014;19(6):469-81. Review.

PMID:
25597356
2.

Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models.

Song G, Darr DB, Santos CM, Ross M, Valdivia A, Jordan JL, Midkiff BR, Cohen S, Nikolaishvili-Feinberg N, Miller CR, Tarrant TK, Rogers AB, Dudley AC, Perou CM, Zamboni WC.

Clin Cancer Res. 2014 Dec 1;20(23):6083-95. doi: 10.1158/1078-0432.CCR-14-0493. Epub 2014 Sep 17.

PMID:
25231403
3.

Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.

Zhang S, Lee DS, Morrissey R, Aponte-Pieras JR, Rogers AB, Moss SF.

Cancer Lett. 2014 Dec 1;355(1):106-12. doi: 10.1016/j.canlet.2014.09.010. Epub 2014 Sep 11.

PMID:
25218349
4.

Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences.

Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I, Kim SG, Li H, Gao Z, Mahana D, Zárate Rodriguez JG, Rogers AB, Robine N, Loke P, Blaser MJ.

Cell. 2014 Aug 14;158(4):705-21. doi: 10.1016/j.cell.2014.05.052.

PMID:
25126780
5.

Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice.

Hartwell HJ, Petrosky KY, Fox JG, Horseman ND, Rogers AB.

Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11455-60. doi: 10.1073/pnas.1404267111. Epub 2014 Jul 21.

6.

Cardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir).

Reyskens KM, Fisher TL, Schisler JC, O'Connor WG, Rogers AB, Willis MS, Planesse C, Boyer F, Rondeau P, Bourdon E, Essop MF.

PLoS One. 2013 Sep 30;8(9):e73347. doi: 10.1371/journal.pone.0073347. eCollection 2013. Erratum in: PLoS One. 2013;8(11). doi:10.1371/annotation/a1e2a42f-7f10-4654-a042-57d19de50208.

7.

Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC.

Zhang Y, Schwerbrock NM, Rogers AB, Kim WY, Huang L.

Mol Ther. 2013 Aug;21(8):1559-69. doi: 10.1038/mt.2013.120. Epub 2013 Jun 18.

8.

CCR2 and CD44 promote inflammatory cell recruitment during fatty liver formation in a lithogenic diet fed mouse model.

Egan CE, Daugherity EK, Rogers AB, Abi Abdallah DS, Denkers EY, Maurer KJ.

PLoS One. 2013 Jun 7;8(6):e65247. doi: 10.1371/journal.pone.0065247. Print 2013.

9.

Delivering a behavior-change weight management program to teachers and state employees in North Carolina.

Dunn C, Whetstone LM, Kolasa KM, Jayaratne KS, Thomas C, Aggarwal S, Herget C, Rogers AB.

Am J Health Promot. 2013 Jul-Aug;27(6):378-83. doi: 10.4278/ajhp.120221-QUAN-101. Epub 2013 Mar 7.

PMID:
23470189
10.

Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development.

Kuwahara Y, Mora-Blanco EL, Banine F, Rogers AB, Fletcher C, Sherman LS, Roberts CW, Weissman BE.

Int J Cancer. 2013 Jun 15;132(12):2767-77. doi: 10.1002/ijc.27976. Epub 2012 Dec 27.

11.

Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib.

Stone SM, Thorpe CM, Ahluwalia A, Rogers AB, Obata F, Vozenilek A, Kolling GL, Kane AV, Magun BE, Jandhyala DM.

Front Cell Infect Microbiol. 2012 Nov 8;2:135. doi: 10.3389/fcimb.2012.00135. eCollection 2012.

12.

Histologic scoring of gastritis and gastric cancer in mouse models.

Rogers AB.

Methods Mol Biol. 2012;921:189-203. Review.

PMID:
23015505
13.
14.
15.

Intestinal inflammation targets cancer-inducing activity of the microbiota.

Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, Jobin C.

Science. 2012 Oct 5;338(6103):120-3. doi: 10.1126/science.1224820. Epub 2012 Aug 16.

16.

The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease.

Daugherity EK, Balmus G, Al Saei A, Moore ES, Abi Abdallah D, Rogers AB, Weiss RS, Maurer KJ.

Cell Cycle. 2012 May 15;11(10):1918-28. doi: 10.4161/cc.20259. Epub 2012 May 15.

17.

NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling.

Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC, Woodford RM, Davis BK, Uronis JM, Herfarth HH, Jobin C, Rogers AB, Ting JP.

Immunity. 2012 May 25;36(5):742-54. doi: 10.1016/j.immuni.2012.03.012. Epub 2012 Apr 12.

18.

Insulin resistance and metabolic hepatocarcinogenesis with parent-of-origin effects in A×B mice.

Hines IN, Hartwell HJ, Feng Y, Theve EJ, Hall GA, Hashway S, Connolly J, Fecteau M, Fox JG, Rogers AB.

Am J Pathol. 2011 Dec;179(6):2855-65. doi: 10.1016/j.ajpath.2011.08.014. Epub 2011 Oct 1.

19.

17 β-estradiol suppresses Helicobacter pylori-induced gastric pathology in male hypergastrinemic INS-GAS mice.

Ohtani M, Ge Z, García A, Rogers AB, Muthupalani S, Taylor NS, Xu S, Watanabe K, Feng Y, Marini RP, Whary MT, Wang TC, Fox JG.

Carcinogenesis. 2011 Aug;32(8):1244-50. doi: 10.1093/carcin/bgr072. Epub 2011 May 11.

20.

Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes.

Liu Y, Johnson SM, Fedoriw Y, Rogers AB, Yuan H, Krishnamurthy J, Sharpless NE.

Blood. 2011 Mar 24;117(12):3257-67. doi: 10.1182/blood-2010-09-304402. Epub 2011 Jan 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk